|
How to close the gap between seeing a signal and acting on it No images? Click here NEW WEBINARTuesday, October 20, 11:00 AM ETPharma R&D has invested millions in digitizing clinical operations, yet many portfolio and program decisions still rely on periodic reviews, static dashboards and manual escalation. Despite significant advances in data and analytics, leaders often struggle to answer critical questions quickly and consistently: Which assets should be accelerated, delayed or deprioritized? Which risks require intervention now? How will emerging operational signals impact timelines, costs and probability of success across the portfolio? As pipelines become more complex and development timelines continue to compress, the gap between seeing a signal and acting on it is emerging as one of the largest barriers to R&D productivity. While organizations have improved visibility, many still lack the ability to systematically translate insights into timely, coordinated decisions. Join industry experts for a discussion on the future of R&D oversight and why the shift from visibility to next best action is becoming essential. The conversation will explore how mission control combines connected data, scenario simulation and agentic AI to help R&D organizations move beyond monitoring performance to receiving real-time, risk-adjusted recommendations that connect cross-functional signals and surface the most effective actions to take next. Attendees will gain perspectives on how leading organizations are rethinking decision-making, improving operational agility and creating a more proactive approach to managing clinical development. The session will include:
MIKE MARTIN PRINCIPAL
VISHAL KABRA PRINCIPAL
NITIN CHAWLA PRINCIPAL
SURANI FERNANDO HEALTHCARE JOURNALIST, WRITER & PODCAST PRODUCER Designed by
Interested in sponsoring your own webinar? Upgrade to a paid subscription. |